Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
AL HADA, PRINCE SULTAN, PRINCE MANSOUR HOSPITALS AND THE REHABILITATION CENTER has floated a tender for Ranibizumab 2.3 Mg\0.23 Ml Intraocular Injection 0.23 Ml Vial. The project location is Saudi Arabia and the tender is closing on 03 Apr 2024. The tender notice number is PR24_7382, while the TOT Ref Number is 99335482. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Saudi Arabia
Summary : Ranibizumab 2.3 Mg\0.23 Ml Intraocular Injection 0.23 Ml Vial
Deadline : 03 Apr 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 99335482
Document Ref. No. : PR24_7382
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Purchaser : AL HADA, PRINCE SULTAN, PRINCE MANSOUR HOSPITALS AND THE REHABILITATION CENTER
Saudi Arabia
[Disclaimer: For Exact Organization/Tendering Authority details, please refer the tender notice.]
Saudi Arabia
Tender Details
RANIBIZUMAB 2.3 MG\0.23 ML INTRAOCULAR INJECTION 0.23 ML VIAL
Purpose of competition: Supply of item RANIBIZUMAB 2.3 MG Supply of item RANIBIZUMAB 2.3 MG\0.23 ML INTRAOCULAR INJECTION 0.23 ML VIAL
Value of competition documents: Free
Reference number: 240339017362
Competition number: PR24_7382
Competition type: Direct purchase
Competition status: Approved
Place of implementation: Within the Kingdom, Makkah Al-Mukarramah region
Documents
Want To Bid in This Tender?
Get Local Agent Support in Saudi Arabia and 60 More Countries.
View Tenders By
Sign in with Google